Company news

Medicure Inc. news in 2021

Medicure Inc.'s news releases, calls and decks from 2021, newest first.

View company

Medicure Reports Financial Results for Quarter Ended September 30, 2021

November 22, 2021

Medicure Plans To Launch Innovative E-Commerce Pharmacy Platform Offering Hundreds of Medications Directly To Millions of Americans

November 22, 2021

Medicure Announces that the Shortened AGGRASTAT® Versus INTEGRILIN® in Percutaneous Coronary Intervention (SAVI-PCI) Study has Met its Primary Endpoint

November 4, 2021

Medicure Announces Grant of Stock Options

July 30, 2021

Medicure Announces Appointment of David Gurvey as Chief Financial Officer

June 24, 2021

Medicure Reports Financial Results for Quarter Ended March 31, 2021

May 10, 2021

Medicure 2020 Annual and Q1 2021 Results and Conference Call Date

May 5, 2021

Medicure Announces Resignation of Chief Financial Officer and Succession Plan

April 28, 2021

Medicure Reports Financial Results for Quarter and Year Ended December 31, 2020

April 20, 2021

Medicure to Participate in Renmark's Virtual Non-Deal Roadshow Series on Tuesday, March 30, 2021

March 29, 2021

Medicure to Participate in Renmark's Virtual Non-Deal Roadshow Series on Tuesday, March 9, 2021

March 8, 2021

Medicure to Participate in Renmark's Virtual Non-Deal Roadshow Series on Tuesday, February 23, 2021

February 22, 2021

Medicure To Participate In Renmark's Virtual Non-Deal Roadshow Series on Monday, February 8, 2021

February 4, 2021

Medicure Announces Early Completion of Enrollment for iSPASM, a Phase 1/2a Exploratory Clinical Trial of AGGRASTAT® (tirofiban hydrochloride) Injection vs. Placebo for Induced Suppression of Platelets Activity in Aneurysmal Subarachnoid Hemorrhage Management

January 27, 2021

Medicure Announces Pivotal Phase 3 Trial IND Filing with FDA for Treatment of Seizures Associated with Pyridox(am)ine 5'-phosphate oxidase (PNPO) Deficiency

January 7, 2021

Calls in 2021

Decks in 2021